31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.

Visa andra versioner (1)

BACKGROUND: The purpose of this work was to further define the value of cardiac 31P magnetic resonance (MR) spectroscopy for patients with coronary artery disease and dilated cardiomyopathy. METHODS AND RESULTS: Blood-corrected and T1-corrected 31P MR spectra of anteroseptal myocardium were obtained...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Neubauer, S, Krahe, T, Schindler, R, Horn, M, Hillenbrand, H, Entzeroth, C, Mader, H, Kromer, E, Riegger, G, Lackner, K
Materialtyp:	Journal article
Språk:	English
Publicerad:	1992

Liknande verk

31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: Altered cardiac high-energy phosphate metabolism in heart failure
av: Neubauer, S, et al.
Publicerad: (1992)

[The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium]
av: Schindler, R, et al.
Publicerad: (1992)

Direct measurements of relaxation times of phosphorus metabolites in the human myocardium
av: Schindler, R, et al.
Publicerad: (1992)

Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T
av: Stoll, V, et al.
Publicerad: (2016)

Cardiac 31P-MR-spectroscopy in myocardial insufficiency
av: Krahe, T, et al.
Publicerad: (1993)

[31P-cardio-MR-spectroscopy in myocardial insufficiency]
av: Krahe, T, et al.
Publicerad: (1993)

Metabolic imaging in dilated cardiomyopathy
av: Neubauer, S
Publicerad: (2011)

Direct measurement of spin-lattice relaxation times of phosphorus metabolites in human myocardium.
av: Neubauer, S, et al.
Publicerad: (1992)

Altered Aortic Hemodynamics and Relative Pressure in Patients with Dilated Cardiomyopathy
av: Marlevi, David
Publicerad: (2021)

[In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results]
av: Krahe, T, et al.
Publicerad: (1991)

Training and myocardial energy metabolism in patients with dilated cardiomyopathy: Analysis with P-31-MR spectroscopy
av: Wagner, D, et al.
Publicerad: (2000)

In vivo 31P cardiac nuclear magnetic resonance spectroscopy. Methods and first clinical results
av: Krahe, T, et al.
Publicerad: (1991)

Dilated cardiomyopathy and the desmin gene.
av: Mayosi, B, et al.
Publicerad: (2000)

Computed tomography and magnetic resonance tomography in cases of coronary heart disease
av: Lackner, K, et al.
Publicerad: (1990)

[Computed tomography and magnetic resonance tomography in cases of coronary heart disease]
av: Lackner, K, et al.
Publicerad: (1990)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
av: Suttie, J, et al.
Publicerad: (2011)

Obesity modifies the energetic phenotype in dilated cardiomyopathy
av: Rayner, JJ, et al.
Publicerad: (2021)

Hyperubiquitination of proteins in dilated cardiomyopathy.
av: Weekes, J, et al.
Publicerad: (2003)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
av: Lakdawala, N, et al.
Publicerad: (2010)

[Experimental and clinical possibilities of MR spectroscopy of the heart]
av: Neubauer, S, et al.
Publicerad: (1991)

Experimental and clinical possibilities of MR spectroscopy of the heart
av: Neubauer, S, et al.
Publicerad: (1991)

Molecular and genetic dissection of dilated cardiomyopathy
av: Hafizah Khalidh
Publicerad: (2015)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
av: Rayner, JJ, et al.
Publicerad: (2020)

Indications for cardio-MRT
av: Lackner, K, et al.
Publicerad: (1990)

[Indications for cardio-MRT]
av: Lackner, K, et al.
Publicerad: (1990)

Exercise training in dilated cardiomyopathy improves rest and stress cardiac function without changes in cardiac high energy phosphate metabolism.
av: Holloway, C, et al.
Publicerad: (2012)

Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
av: Neubauer, S, et al.
Publicerad: (1997)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
av: Watkins, H
Publicerad: (2003)

Reevaluating the genetic contribution of monogenic dilated cardiomyopathy
av: Mazzarotto, F, et al.
Publicerad: (2020)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
av: Ashrafian, H, et al.
Publicerad: (2007)

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.
av: Konstantinou, D, et al.
Publicerad: (2014)

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy
av: Konstantinou, D, et al.
Publicerad: (2014)

Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease.
av: Neubauer, S, et al.
Publicerad: (1995)

Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy.
av: Beer, M, et al.
Publicerad: (2008)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
av: Robinson, P, et al.
Publicerad: (2002)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
av: Robinson, P, et al.
Publicerad: (2003)

Investigation of a transgenic mouse model of familial dilated cardiomyopathy.
av: Song, W, et al.
Publicerad: (2010)

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
av: Borovikov, I, et al.
Publicerad: (2013)

Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T 31P-cardiovascular magnetic resonance spectroscopy
av: Valkovič, L, et al.
Publicerad: (2019)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
av: Robinson, P, et al.
Publicerad: (2002)